Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Tandem Diabetes Care (TNDM) over the last 14 years, with Q3 2025 value amounting to $22.5 million.

  • Tandem Diabetes Care's Gains from Investment Securities rose 39851.74% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.5 million, marking a year-over-year increase of 9546.49%. This contributed to the annual value of $4.4 million for FY2024, which is 3711.95% up from last year.
  • According to the latest figures from Q3 2025, Tandem Diabetes Care's Gains from Investment Securities is $22.5 million, which was up 39851.74% from -$1.0 million recorded in Q2 2025.
  • Over the past 5 years, Tandem Diabetes Care's Gains from Investment Securities peaked at $107.5 million during Q1 2022, and registered a low of -$4.7 million during Q4 2024.
  • Moreover, its 5-year median value for Gains from Investment Securities was $1.3 million (2023), whereas its average is $8.4 million.
  • Per our database at Business Quant, Tandem Diabetes Care's Gains from Investment Securities skyrocketed by 280673.08% in 2022 and then crashed by 359166.67% in 2023.
  • Over the past 5 years, Tandem Diabetes Care's Gains from Investment Securities (Quarter) stood at $104000.0 in 2021, then skyrocketed by 2806.73% to $3.0 million in 2022, then tumbled by 34.8% to $2.0 million in 2023, then tumbled by 336.53% to -$4.7 million in 2024, then surged by 583.23% to $22.5 million in 2025.
  • Its Gains from Investment Securities was $22.5 million in Q3 2025, compared to -$1.0 million in Q2 2025 and $4.7 million in Q1 2025.